Lanean...

Linking SOX10 to a slow-growth resistance phenotype

Slow-cycling BRAF(V600E) melanoma cells are notoriously resistant to standard chemotherapy or targeted therapy but the underlying mechanism remains elusive. Now a new study unlocks this mystery and offers novel insights into developing more effective therapeutic interventions.

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zhang, Gao, Herlyn, Meenhard
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123291/
https://ncbi.nlm.nih.gov/pubmed/24853952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.67
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!